The objective of this study was to evaluate the effects of antimicrobial drug use, gastric acid-
suppressive agent use, and infection control practices on the incidence of Clostridium …

Objective. To determine which antibiotics increase or decrease the risk of Clostridium
difficile-associated diarrhea (CDAD). Design. Retrospective case-control study. Setting …

Background Clostridium difficile is the leading cause of nosocomial infectious diarrhea.
Hospitalized patients were at risk of C. difficile-associated diarrhea (CDAD). However the …

The incidence of Clostridium difficile-associated diarrhea (CDAD) has increased
dramatically in hospitals worldwide during the past 2 decades. In Western Australia, this …

Objective: To determine modifiable risk factors for nosocomial Clostridium difficile-
associated diarrhea (CDAD). Design: Case-control study. Setting: 300-bed tertiary-care …

Background: Clostridium difficile-associated diarrhea (CDAD) is an important infection in
hospital settings. Its impact on outpatient care has not been well defined. Objective: To …

Objectives: To evaluate the effectiveness of specific infection control measures on the
incidence of Clostridium difficile-associated diarrhea (CDAD) and to identify risk factors for …

Clostridium difficile is the most common cause of hospital-acquired diarrhea in patients
treated with antibiotics, chemotherapeutic agents, and other drugs that alter the normal …

Background. Since 2002, an epidemic of Clostridium difficile–associated-diarrhea (CDAD)
associated with a high case-fatality rate has involved> 30 hospitals in the province of …

BACKGROUND: Recent publications report that gatifloxacin might be associated with a
greater incidence of Clostridium difficile-associated diarrhea (C. difficile, CDAD) than are …